PhysioSeq2Seq: A Hybrid Physiological Digital Twin and Sequence-to-Sequence LSTM for Long-Horizon Glucose Forecasting in Type 1 Diabetes

• URL: http://arxiv.org/abs/2605.16860v1
• Date: Sat, 16 May 2026 07:50:00 GMT
• Title: PhysioSeq2Seq: A Hybrid Physiological Digital Twin and Sequence-to-Sequence LSTM for Long-Horizon Glucose Forecasting in Type 1 Diabetes
• Abstract summary: We propose PhysioSeq2Seq, a hybrid architecture that combines patient-specific physiological modeling with a sequence-to-sequence (Seq2Seq) LSTM.<n>For each glucose segment, twin matching searches a population of 300 parameterized digital twins to identify the best-fitting physiological match.<n>At the 240-minute horizon, PhysioSeq2Seq achieves a mean absolute error of 39.28 mg/dL and a mean error of -10.62 mg/dL.
• Score: 5.419429818864184
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Accurate long-horizon glucose forecasting is critical for automated insulin delivery systems, which help people with type 1 diabetes (T1D) manage their glucose and avoid dangerous hypoglycemia. However, standard recursive long short-term memory (LSTM) networks suffer from systematic negative bias at longer horizons due to error compounding, while purely mechanistic ordinary differential equation (ODE) models fail to generalize across individuals when parameterized at the population level. We propose PhysioSeq2Seq, a hybrid architecture that combines patient-specific physiological modeling with a sequence-to-sequence (Seq2Seq) LSTM. For each glucose segment, twin matching searches a population of 300 parameterized digital twins to identify the best-fitting physiological match from a 3-hour continuous glucose monitoring (CGM) history. The 10 internal ODE state variables of the matched twin are injected as exogenous covariates into both the encoder and decoder of the Seq2Seq LSTM. This simultaneous 48-step prediction strategy eliminates recursive error compounding, while the ODE features provide a physics-grounded constraint that bounds long-horizon drift within physiologically plausible ranges. PhysioSeq2Seq was trained on CGM and insulin data from 348 participants in the Type 1 Diabetes Exercise Initiative (T1DEXI) dataset and evaluated on 74 held-out participants. At the 240-minute horizon, PhysioSeq2Seq achieves a mean absolute error of 39.28 mg/dL and a mean error of -10.62 mg/dL, reducing bias by 13.89 mg/dL over the recursive LSTM and reducing mean absolute error by 28.62 mg/dL over the ODE-based digital twin. These results show that eliminating architectural feedback and injecting patient-matched physiological states is an effective and clinically meaningful strategy for long-horizon glucose forecasting in T1D.

Related papers

• Integrating Neural Differential Forecasting with Safe Reinforcement Learning for Blood Glucose Regulation [51.12307713554633]
  TSODE is a safety-aware controller that integrates Thompson RL Sampling with a Neural Ordinary Differential Equation forecaster.<n>In the FDA-approved UVa/Padova simulator (adult cohort), TSODE achieved 87.9% time-in-range with less than 10% time below 70 mg/dL.
  arXiv  Detail & Related papers  (2025-11-16T02:11:33Z)
• Organ-Agents: Virtual Human Physiology Simulator via LLMs [66.40796430669158]
  Organ-Agents is a multi-agent framework that simulates human physiology via LLM-driven agents.<n>We curated data from 7,134 sepsis patients and 7,895 controls, generating high-resolution trajectories across 9 systems and 125 variables.<n>Organ-Agents achieved high simulation accuracy on 4,509 held-out patients, with per-system MSEs 0.16 and robustness across SOFA-based severity strata.
  arXiv  Detail & Related papers  (2025-08-20T01:58:45Z)
• A Physiologically-Constrained Neural Network Digital Twin Framework for Replicating Glucose Dynamics in Type 1 Diabetes [2.1271939534174673]
  Simulating glucose dynamics in individuals with type 1 diabetes (T1D) is critical for developing personalized treatments and supporting data-driven clinical decisions.<n>Here, we introduce physiologically neural network (NN) digital twins to simulate glucose dynamics in T1D.<n>Across 394 digital twins, glucose outcomes were equivalent between simulated and observed data.
  arXiv  Detail & Related papers  (2025-08-07T03:46:06Z)
• GlyTwin: Digital Twin for Glucose Control in Type 1 Diabetes Through Optimal Behavioral Modifications Using Patient-Centric Counterfactuals [6.102406188211489]
  We propose GlyTwin, a novel digital twin framework that uses counterfactual explanations to simulate optimal treatments for glucose regulation.<n>GlyTwin generates behavioral treatment suggestions that proactively prevent hyperglycemia.<n>Results show GlyTwin outperforms state-of-the-art counterfactual methods, generating 76.6% valid and 86% effective interventions.
  arXiv  Detail & Related papers  (2025-04-14T03:32:39Z)
• Integrating Biological-Informed Recurrent Neural Networks for Glucose-Insulin Dynamics Modeling [1.2256664621079256]
  This study introduces a Biological-Informed Recurrent Neural Network (BIRNN) framework to address these limitations.<n>The framework is validated using the commercial UVA/Padova simulator, outperforming traditional linear models in glucose prediction accuracy and reconstruction of unmeasured states.<n>Results demonstrate the potential of BIRNN for personalized glucose regulation and future adaptive control strategies in AP systems.
  arXiv  Detail & Related papers  (2025-03-24T21:26:12Z)
• Type 1 Diabetes Management using GLIMMER: Glucose Level Indicator Model with Modified Error Rate [6.102406188211489]
  We introduce GLIMMER, a machine learning-based model for predicting blood glucose levels.<n>GLIMMER classifies glucose values into normal and abnormal ranges and employs a novel custom loss function.<n>These results represent a 23% improvement in RMSE and a 31% improvement in MAE compared to the best previously reported models.
  arXiv  Detail & Related papers  (2025-02-20T01:26:00Z)
• From Glucose Patterns to Health Outcomes: A Generalizable Foundation Model for Continuous Glucose Monitor Data Analysis [47.23780364438969]
  We present GluFormer, a generative foundation model for CGM data that learns nuanced glycemic patterns and translates them into predictive representations of metabolic health.<n>GluFormer generalizes to 19 external cohorts spanning different ethnicities and ages, 5 countries, 8 CGM devices, and diverse pathophysiological states.<n>In a longitudinal study of 580 adults with CGM data and 12-year follow-up, GluFormer identifies individuals at elevated risk of developing diabetes more effectively than blood HbA1C%.
  arXiv  Detail & Related papers  (2024-08-20T13:19:06Z)
• Continuous time recurrent neural networks: overview and application to forecasting blood glucose in the intensive care unit [56.801856519460465]
  Continuous time autoregressive recurrent neural networks (CTRNNs) are a deep learning model that account for irregular observations. We demonstrate the application of these models to probabilistic forecasting of blood glucose in a critical care setting.
  arXiv  Detail & Related papers  (2023-04-14T09:39:06Z)
• Generalizing electrocardiogram delineation: training convolutional neural networks with synthetic data augmentation [63.51064808536065]
  Existing databases for ECG delineation are small, being insufficient in size and in the array of pathological conditions they represent. This article delves has two main contributions. First, a pseudo-synthetic data generation algorithm was developed, based in probabilistically composing ECG traces given "pools" of fundamental segments, as cropped from the original databases, and a set of rules for their arrangement into coherent synthetic traces. Second, two novel segmentation-based loss functions have been developed, which attempt at enforcing the prediction of an exact number of independent structures and at producing closer segmentation boundaries by focusing on a reduced number of samples.
  arXiv  Detail & Related papers  (2021-11-25T10:11:41Z)
• Stacked LSTM Based Deep Recurrent Neural Network with Kalman Smoothing for Blood Glucose Prediction [4.040272012640556]
  We propose a novel approach to predicting blood glucose level with a stacked Long short-term memory (LSTM) based deep recurrent neural network (RNN) model. For the OhioT1DM dataset, containing eight weeks' data from six different patients, we achieve an average RMSE of 6.45 and 17.24 mg/dl for 30 minutes and 60 minutes of prediction horizon (PH) Our results indicate that the proposed approach is feasible for more reliable BG forecasting that might improve the performance of the artificial pancreas and insulin infusion system for T1D diabetes management.
  arXiv  Detail & Related papers  (2021-01-18T02:31:38Z)
• CovidDeep: SARS-CoV-2/COVID-19 Test Based on Wearable Medical Sensors and Efficient Neural Networks [51.589769497681175]
  The novel coronavirus (SARS-CoV-2) has led to a pandemic. The current testing regime based on Reverse Transcription-Polymerase Chain Reaction for SARS-CoV-2 has been unable to keep up with testing demands. We propose a framework called CovidDeep that combines efficient DNNs with commercially available WMSs for pervasive testing of the virus.
  arXiv  Detail & Related papers  (2020-07-20T21:47:28Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.